These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 21150341
1. Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility. Lawton M, Tong M, Gundogan F, Wands JR, de la Monte SM. Oxid Med Cell Longev; 2010; 3(5):347-56. PubMed ID: 21150341 [Abstract] [Full Text] [Related]
2. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Zheng X, Linke S, Dias JM, Zheng X, Gradin K, Wallis TP, Hamilton BR, Gustafsson M, Ruas JL, Wilkins S, Bilton RL, Brismar K, Whitelaw ML, Pereira T, Gorman JJ, Ericson J, Peet DJ, Lendahl U, Poellinger L. Proc Natl Acad Sci U S A; 2008 Mar 04; 105(9):3368-73. PubMed ID: 18299578 [Abstract] [Full Text] [Related]
5. Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells. Lahousse SA, Carter JJ, Xu XJ, Wands JR, de la Monte SM. BMC Cell Biol; 2006 Dec 07; 7():41. PubMed ID: 17156427 [Abstract] [Full Text] [Related]
6. Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha. Shin DH, Li SH, Yang SW, Lee BL, Lee MK, Park JW. FEBS J; 2009 Jul 07; 276(13):3470-80. PubMed ID: 19456861 [Abstract] [Full Text] [Related]
7. Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis. Lizarazo D, Zabala V, Tong M, Longato L, de la Monte SM. J Gastroenterol Hepatol; 2013 Oct 07; 28(10):1660-8. PubMed ID: 23802886 [Abstract] [Full Text] [Related]
8. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. Coleman ML, McDonough MA, Hewitson KS, Coles C, Mecinovic J, Edelmann M, Cook KM, Cockman ME, Lancaster DE, Kessler BM, Oldham NJ, Ratcliffe PJ, Schofield CJ. J Biol Chem; 2007 Aug 17; 282(33):24027-38. PubMed ID: 17573339 [Abstract] [Full Text] [Related]
9. Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway. Chen DY, Fabrizio JA, Wilkins SE, Dave KA, Gorman JJ, Gleadle JM, Fleming SB, Peet DJ, Mercer AA. J Virol; 2017 Jan 01; 91(1):. PubMed ID: 27795413 [Abstract] [Full Text] [Related]
10. Factor inhibiting HIF (FIH) recognizes distinct molecular features within hypoxia-inducible factor-α (HIF-α) versus ankyrin repeat substrates. Wilkins SE, Karttunen S, Hampton-Smith RJ, Murchland I, Chapman-Smith A, Peet DJ. J Biol Chem; 2012 Mar 16; 287(12):8769-81. PubMed ID: 22270367 [Abstract] [Full Text] [Related]
11. Ferritin heavy chain controls the HIF-driven hypoxic response by activating the asparaginyl hydroxylase FIH. Jin P, Kang J, Lee MK, Park JW. Biochem Biophys Res Commun; 2018 May 15; 499(3):475-481. PubMed ID: 29580991 [Abstract] [Full Text] [Related]
12. A dynamic model of the hypoxia-inducible factor 1α (HIF-1α) network. Nguyen LK, Cavadas MA, Scholz CC, Fitzpatrick SF, Bruning U, Cummins EP, Tambuwala MM, Manresa MC, Kholodenko BN, Taylor CT, Cheong A. J Cell Sci; 2013 Mar 15; 126(Pt 6):1454-63. PubMed ID: 23390316 [Abstract] [Full Text] [Related]
13. Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1). Wilkins SE, Hyvärinen J, Chicher J, Gorman JJ, Peet DJ, Bilton RL, Koivunen P. Int J Biochem Cell Biol; 2009 Jul 15; 41(7):1563-71. PubMed ID: 19401150 [Abstract] [Full Text] [Related]
14. Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival. Kiriakidis S, Henze AT, Kruszynska-Ziaja I, Skobridis K, Theodorou V, Paleolog EM, Mazzone M. FASEB J; 2015 Jul 15; 29(7):2814-27. PubMed ID: 25837583 [Abstract] [Full Text] [Related]
16. MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH). Webb JD, Murányi A, Pugh CW, Ratcliffe PJ, Coleman ML. Biochem J; 2009 May 13; 420(2):327-33. PubMed ID: 19245366 [Abstract] [Full Text] [Related]
17. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M, Carter JJ, Lahousse SA, Califano S, Maeda T, Ueno T, D'Errico A, Trevisani F, Wands JR. J Hepatol; 2006 May 13; 44(5):971-83. PubMed ID: 16564107 [Abstract] [Full Text] [Related]